Brainstorm Cell Therapeutics (BCLI)
NASDAQ:BCLI
Holding BCLI?
Track your performance easily

Brainstorm Cell Therapeutics (BCLI) Stock Investors

519 Followers
Based on 757,103 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold BCLI
On average, investors allocate 0.00% of their portfolios to BCLI
The average holding size of this company in investors' portfolios.

Investor Sentiment

Neutral
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 757,103 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding BCLI

1.7%
Last 7
Days
2.5%
Last 30
Days
Percentages indicate the change in the number of portfolios holding BCLI, out of 757,103 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

BCLI Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,467 investors who made their portfolios public
The table shows changes in BCLI in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

BCLI Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Blink Charging Co
5.32%
-1.79%
-3.85%
190.16M
Industrials
DraftKings
5.58%
-1.48%
+0.87%
34.22B
Consumer Cyclical
Bristol-Myers Squibb
3.44%
-1.33%
-2.60%
100.34B
Healthcare
Plug Power
5.11%
-1.24%
-2.96%
1.84B
Industrials
Coherus Biosciences
2.45%
-0.19%
-1.47%
119.82M
Healthcare
Marathon Digital Holdings
5.33%
-0.71%
-1.46%
4.67B
Financial
Citigroup
4.77%
+0.13%
+0.21%
113.11B
Financial
GE Aerospace
5.34%
+1.00%
+4.32%
195.53B
Industrials
Li Auto
5.54%
-1.52%
-3.63%
20.10B
Consumer Cyclical
XPeng, Inc. ADR
5.47%
-1.34%
-2.89%
8.61B
Consumer Cyclical
Based on the activity of 757,103 active portfolios
Open your Smart Portfolio

BCLI Investor Analysis

BCLI investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
13.5%
of BCLI holders
are under 35
Average Segment Performance
Average P/E Ratio20.16
Beta8.32
Dividend Yield3.50%
BCLI investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
61.5%
of BCLI holders
are between 35–55
Average Segment Performance
Average P/E Ratio18.25
Beta13.76
Dividend Yield3.65%
BCLI investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
25.0%
of BCLI holders
are over 55
Average Segment Performance
Average P/E Ratio20.06
Beta4.95
Dividend Yield3.36%
Overview of age group and performance of BCLI stock investors
See who invests in BCLI according to age group and performance.

FAQ

How many retail Investors hold BCLI?
<0.1% of TipRanks' retail investors hold BCLI in their portfolios.
    What is BCLI Investor Sentiment?
    BCLI’s Investor Sentiment is Neutral.
      What percentage of retail investors changed their holding of BCLI in the last 7 days?
      ▼ 1.7% of TipRanks' retail investors changed their holding of BCLI in the last 7 days.
        What percentage of retail investors changed their holding of BCLI in the last 30 days?
        ▲ 2.5% of TipRanks' retail investors changed their holding of BCLI in the last 30 days.
          What is the average age of retail investors who hold BCLI?
          The average age of BCLI Holders is between 35–55.
            What other stocks have BCLI investors also bought?
            BCLI Investors also bought BLNK, DKNG, BMY, PLUG, CHRS, MARA, C, GE, LI, XPEV.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              BMRNBioMarin Pharmaceutical
              BSXBoston Scientific
              CPRXCatalyst Pharma
              EXELExelixis
              AVDLAvadel Pharmaceuticals
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis